ОбзорГрафикНовостиTraderScreen

BNP Paribas Discount Zert AZN 27..../  DE000PC93A07  /

Frankfurt Zert./BNP
15.11.2024  17:20:31 Изменение-3.270 Бид17:29:38 Предложение17:29:38 Базовый актив Цена исполнения Дата истечения Тип опциона
115.780EUR -2.75% 115.430
Величина цены спроса: 1,000		 115.530
Величина цены предложения: 1,000		 Astrazeneca PLC ORD ... - GBP 27.03.2025 Call
TeleTrader 12.11 AstraZeneca's revenue in Q3 rises 21% to $13.5B
GlobeNewswire 12.08 Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire 08.08 Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire 06.08 Cellectis Provides Financial Results for the Second Quarter 2024
TeleTrader 25.07 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 15.07 AstraZeneca Closes Acquisition of Amolyt Pharma
GlobeNewswire 26.06 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 18.06 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 18.06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 13.06 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 28.05 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 21.05 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 20.05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 08.05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 06.05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06.05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 29.04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25.04 Europe opens mostly down after corporate earnings
TeleTrader 25.04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 28.03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 19.03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18.03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14.03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14.03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 28.02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates